Globe Life Sciences provides commercial evaluation and information services within healthcare-related sectors. The company specialises in the evaluation of products, diseases and companies to support ...

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to ...

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to ...

AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...

Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ...

Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

The US FDA has approved the first ever cell-based gene therapy to treat Wiskott-Aldrich syndrome (WAS).

The industry is now entering the next era by embedding AI directly into the software field teams’ use every day. The step ...

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care ...

Eli Lilly and Indiana University (IU) have announced a new agreement, under which Lilly will provide up to $40m to IU in ...

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...